Trandolapril/verapamil
From Self-sufficiency
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (February 2009) |
This article may need to be updated. Please update this article to reflect recent events or newly available information, and remove this template when finished. |
Tarka is the brand name of an oral antihypertensive medication that combines a slow release formulation of verapamil hydrochloride, a calcium channel blocker, and an immediate release formulation of trandolapril, an ACE inhibtor. The patent, held by Abbott Laboratories, expired on June 12, 2007.
| 40px | This antihypertensive-related article is a stub. You can help ssf by expanding it. |
Categories:
- Articles lacking sources from December 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Orphaned articles from February 2009
- All orphaned articles
- Wikipedia articles in need of updating
- Calcium channel blockers
- ACE inhibitors
- Antihypertensive agent stubs
- 2Fix
